| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C0006826> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C0020964> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C0027651> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C0039215> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C0086692> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C2986635> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34011563_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies,\' University of Tübingen, Tübingen, Germany.\', \'Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.\', \'Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.\', \'Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.\', \'Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.\', \'Department for Hematology and Oncology, University Hospital Bonn, Bonn, Germany.\', \'Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany.\', \'Department of Urology, Medical Faculty and University Hospital, Eberhard-Karls-University Tübingen, Tübingen, Germany.\', \'German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.\', \'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.\', \'Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bauer_Jens> <https://research.tib.eu/covid-19/entity/Berner_Fiamma> <https://research.tib.eu/covid-19/entity/Bilich_Tatjana> <https://research.tib.eu/covid-19/entity/Brossart_Peter> <https://research.tib.eu/covid-19/entity/Dubbelaar_Marissa_L> <https://research.tib.eu/covid-19/entity/Erne_Eva> <https://research.tib.eu/covid-19/entity/Flatz_Lukas> <https://research.tib.eu/covid-19/entity/H%C3%B6rber_Sebastian> <https://research.tib.eu/covid-19/entity/Heitmann_Jonas_S> <https://research.tib.eu/covid-19/entity/Held_Stefanie> <https://research.tib.eu/covid-19/entity/Klein_Reinhild> <https://research.tib.eu/covid-19/entity/M%C3%A4rklin_Melanie> <https://research.tib.eu/covid-19/entity/Maringer_Yacine> <https://research.tib.eu/covid-19/entity/Nelde_Annika> <https://research.tib.eu/covid-19/entity/Peter_Andreas> <https://research.tib.eu/covid-19/entity/Rammensee_Hans-Georg> <https://research.tib.eu/covid-19/entity/Rieth_Jonas> <https://research.tib.eu/covid-19/entity/Roerden_Malte> <https://research.tib.eu/covid-19/entity/Salih_Helmut_R> <https://research.tib.eu/covid-19/entity/Wacker_Marcel> <https://research.tib.eu/covid-19/entity/Wagner_Philipp> <https://research.tib.eu/covid-19/entity/Walz_Juliane_S>
?:doi	<https://research.tib.eu/covid-19/entity/10.1158/2159-8290.CD-21-0191>
?:doi	10.1158/2159-8290.CD-21-0191
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Comment> <https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Cancer discovery
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34011563>
?:pmid	<https://research.tib.eu/covid-19/entity/34011563>
?:pmid	34011563
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	6.996
?:rankingScore_hIndex	98
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0311392_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C1842211_PROCESS_OF_C1708335> <https://research.tib.eu/covid-19/entity/C2673463_PROCESS_OF_C0030705>
?:title	Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies,\' University of Tübingen, Tübingen, Germany.\', \'Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.\', \'Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.\', \'Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.\', \'Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.\', \'Department of Dermatology, University Hospital Tübingen, Tübingen, Germany.\', \'Department for Hematology and Oncology, University Hospital Bonn, Bonn, Germany.\', \'Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany.\', \'Department of Urology, Medical Faculty and University Hospital, Eberhard-Karls-University Tübingen, Tübingen, Germany.\', \'German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.\', \'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany. juliane.walz@med.uni-tuebingen.de.\', \'Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany.\']

?:citedBy